EIKEN CHEMICAL CO.,LTD. Logo

EIKEN CHEMICAL CO.,LTD.

Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.

4549 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
台東区台東四丁目19番9号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eiken Chemical Co., Ltd., founded in 1939, is a manufacturer specializing in clinical diagnostics. The company's core business involves the development, manufacturing, and sale of pharmaceuticals, reagents, and medical and scientific equipment. Eiken Chemical is a global leader in Fecal Immunochemical Test (FIT) systems, such as its OC-Sensor series, for the early detection of colorectal cancer. Its portfolio also includes microbiological tests for food poisoning bacteria and environmental inspection, serving the broader healthcare and research markets. The company provides comprehensive solutions from sample collection to result reporting for its diagnostic systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 07:32
Prospectus
発行登録書(株券、社債券等)
Japanese 32.0 KB
2025-08-08 09:09
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2025-07-10 08:23
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.4 KB
2025-06-25 03:09
Regulatory News Service
訂正発行登録書
Japanese 10.2 KB
2025-06-25 03:05
Regulatory News Service
臨時報告書
Japanese 32.3 KB
2025-06-25 03:00
Governance Information
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 27.1 KB
2025-06-25 03:00
Registration Form
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2025-06-25 03:00
Registration Form
確認書
Japanese 9.1 KB
2025-06-24 09:54
Registration Form
訂正発行登録書
Japanese 10.2 KB
2025-06-24 09:51
Share Issue/Capital Change
臨時報告書
Japanese 39.7 KB
2025-06-10 09:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.0 KB
2025-05-12 03:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.2 KB
2025-04-10 05:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.2 KB
2025-03-25 04:52
Registration Form
訂正発行登録書
Japanese 10.3 KB
2025-03-25 04:51
Regulatory News Service
訂正発行登録書
Japanese 10.3 KB

Automate Your Workflow. Get a real-time feed of all EIKEN CHEMICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EIKEN CHEMICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea 314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea 358570
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea 204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan 2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary GWPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.